204 related articles for article (PubMed ID: 31010616)
1. Risk of prolonged opioid use among cancer patients undergoing curative intent radiation therapy for head and neck malignancies.
Smith WH; Luskin I; Resende Salgado L; Scarborough BM; Lin JY; Özbek U; Miles BA; Gupta V; Bakst RL
Oral Oncol; 2019 May; 92():1-5. PubMed ID: 31010616
[TBL] [Abstract][Full Text] [Related]
2. Opioid therapy vs. multimodal analgesia in head and neck Cancer (OPTIMAL-HN): study protocol for a randomized clinical trial.
Zayed S; Lang P; Mendez LC; Read N; Sathya J; Venkatesan V; Moulin DE; Warner A; Palma DA
BMC Palliat Care; 2021 Mar; 20(1):45. PubMed ID: 33740977
[TBL] [Abstract][Full Text] [Related]
3. Acute toxicity in comprehensive head and neck radiation for nasopharynx and paranasal sinus cancers: cohort comparison of 3D conformal proton therapy and intensity modulated radiation therapy.
McDonald MW; Liu Y; Moore MG; Johnstone PA
Radiat Oncol; 2016 Feb; 11():32. PubMed ID: 26922239
[TBL] [Abstract][Full Text] [Related]
4. Long-term opioid use in patients treated with head and neck intensity-modulated radiotherapy.
Zhao L; Moon DH; Avkshtol V; Siropaides CH; Terauchi S; Day AT; Sumer BD; Hughes R; Sher DJ
Support Care Cancer; 2022 Sep; 30(9):7517-7525. PubMed ID: 35666302
[TBL] [Abstract][Full Text] [Related]
5. New Persistent Opioid Use Among Patients With Cancer After Curative-Intent Surgery.
Lee JS; Hu HM; Edelman AL; Brummett CM; Englesbe MJ; Waljee JF; Smerage JB; Griggs JJ; Nathan H; Jeruss JS; Dossett LA
J Clin Oncol; 2017 Dec; 35(36):4042-4049. PubMed ID: 29048972
[TBL] [Abstract][Full Text] [Related]
6. Lipid microsphere bound oxycodone for pain management in patients receiving radiotherapy for head and neck cancer.
McDonald AM; Spencer SA; Willey CD; Bonner JA; Dobelbower MC; Swain TA; Nabell L; McCammon S; Carroll WR; McGwin G; Bhatia S; Yang ES
Support Care Cancer; 2021 Jan; 29(1):263-269. PubMed ID: 32350670
[TBL] [Abstract][Full Text] [Related]
7. Incidence and Predictors of Persistent Opioid Use in Survivors of Head and Neck Cancer Treated With Curative Radiation.
Ganju R; Neeranjun R; Morse R; Lominska C; TenNapel M; Chen AM
Am J Clin Oncol; 2022 Apr; 45(4):161-167. PubMed ID: 35131971
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma.
Kubota H; Miyawaki D; Mukumoto N; Ishihara T; Matsumura M; Hasegawa T; Akashi M; Kiyota N; Shinomiya H; Teshima M; Nibu KI; Sasaki R
Radiat Oncol; 2021 Jan; 16(1):1. PubMed ID: 33402192
[TBL] [Abstract][Full Text] [Related]
9. Pain management in patients undergoing radiation therapy for head and neck cancer - a descriptive study.
Schaller AKCS; Peterson A; Bäckryd E
Scand J Pain; 2021 Apr; 21(2):256-265. PubMed ID: 34387952
[TBL] [Abstract][Full Text] [Related]
10. Opioid use patterns in patients with head and neck cancer receiving radiation therapy: Single-institution retrospective analysis characterizing patients who did not require opioid therapy.
Rich BJ; Schumacher LD; Sargi ZB; Masforroll M; Kwon D; Zhao W; Rueda-Lara MA; Freedman LM; Elsayyad N; Samuels SE; Abramowitz MC; Samuels MA
Head Neck; 2021 Oct; 43(10):2973-2984. PubMed ID: 34143542
[TBL] [Abstract][Full Text] [Related]
11. Predictors of long-term opioid treatment among patients who receive chemoradiation for head and neck cancer.
Kwon JH; Hui D; Chisholm G; Bruera E
Oncologist; 2013 Jun; 18(6):768-74. PubMed ID: 23723332
[TBL] [Abstract][Full Text] [Related]
12. Fentanyl pectin nasal spray for painful mucositis in head and neck cancers during intensity-modulated radiation therapy with or without chemotherapy.
Mazzola R; Ricchetti F; Fiorentino A; Giaj-Levra N; Fersino S; Tebano U; Albanese S; Gori S; Alongi F
Clin Transl Oncol; 2017 May; 19(5):593-598. PubMed ID: 27853984
[TBL] [Abstract][Full Text] [Related]
13. Long-term opioid use in curative-intent radiotherapy: One-Year outcomes in head/neck cancer patients.
Schumacher LD; Sargi ZB; Masforroll M; Kwon D; Zhao W; Rueda-Lara MA; Freedman LM; Elsayyad N; Samuels SE; Abramowitz MC; Samuels MA
Head Neck; 2020 Apr; 42(4):608-624. PubMed ID: 31785054
[TBL] [Abstract][Full Text] [Related]
14. Persistent opioid use after radiation therapy in opioid-naive cervical cancer survivors.
Ward K; Ramzan A; Sheeder J; Fischer S; Lefkowits C
Int J Gynecol Cancer; 2019 Sep; 29(7):1105-1109. PubMed ID: 31420413
[TBL] [Abstract][Full Text] [Related]
15. Rates and risk factors for prolonged opioid use after major surgery: population based cohort study.
Clarke H; Soneji N; Ko DT; Yun L; Wijeysundera DN
BMJ; 2014 Feb; 348():g1251. PubMed ID: 24519537
[TBL] [Abstract][Full Text] [Related]
16. Locoregional Control and Toxicity in Head and Neck Carcinoma Patients following Helical Tomotherapy-Delivered Intensity-Modulated Radiation Therapy Compared with 3D-CRT Data.
Santa Cruz O; Tsoutsou P; Castella C; Khanfir K; Anchisi S; Bouayed S; Matzinger O; Ozsahin M
Oncology; 2018; 95(2):61-68. PubMed ID: 29895020
[TBL] [Abstract][Full Text] [Related]
17. Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses.
Takiar V; Garden AS; Ma D; Morrison WH; Edson M; Zafereo ME; Gunn GB; Fuller CD; Beadle B; Frank SJ; William WN; Kies M; El-Naggar AK; Weber R; Rosenthal DI; Phan J
Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1117-31. PubMed ID: 27354127
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of tapentadol prolonged release for the management of painful mucositis in head and neck cancers during intensity modulated radiation therapy.
Rosario M; Francesco R; Sergio F; Niccolò GL; Alba F; Maurizio N; Sergio A; Stefania G; Filippo A
Support Care Cancer; 2016 Oct; 24(10):4451-5. PubMed ID: 27448104
[TBL] [Abstract][Full Text] [Related]
19. Incidence and Risk Factors for Chronic Postoperative Opioid Use After Major Spine Surgery: A Cross-Sectional Study With Longitudinal Outcome.
Dunn LK; Yerra S; Fang S; Hanak MF; Leibowitz MK; Tsang S; Durieux ME; Nemergut EC; Naik BI
Anesth Analg; 2018 Jul; 127(1):247-254. PubMed ID: 29570151
[TBL] [Abstract][Full Text] [Related]
20. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
